Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.	Fin. Year	Received	Resolved*
1	2022-23	1	1
2	2023-24	0	0
3	2024-25	0	0
4	2025-26	1	1
	Grand Total	2	2

Top Pharma Companies in India by Market Cap

BSE Sensex 75533.76 1074.23 (1.44%)

Filter

Top Pharma Companies in India as on Nov-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

Expand company details	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)	More company information
61	Kovai Medical Center & Hospital Ltd.	Q V PT	6,356 Small Cap	5,734.45 (-1.27%)	24.8	4.58	18.09	25.97	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
62	NGL Fine-Chem Ltd.	Q V PT	1,576 Small Cap	2,557.20 (0.24%)	27.55	4.53	14.19	-3.22	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
63	Park Medi World Ltd.	Q V PT	9,513 Small Cap	223.70 (1.57%)	36.86	4.53	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
64	Morepen Laboratories Ltd.	Q V+ PT	6,230 Small Cap	108.05 (-4.97%)	33.04	4.51	8.73	-11.54	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
65	Cohance Lifesciences Ltd.	Q V+ PT	17,005 Small Cap	449.25 (1.08%)	160.07	4.42	17.57	-18.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
66	Vimta Labs Ltd.	Q V+ PT	2,167 Small Cap	488.30 (0.71%)	26.97	4.41	14.27	28.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
67	Marksans Pharma Ltd.	Q V+ PT	13,896 Small Cap	310.05 (1.11%)	26.89	4.37	16.48	7.89	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
68	Sun Pharma Advanced Research Company Ltd.	Q V+ PT	5,741 Small Cap	175.45 (-0.82%)	3.62	4.36	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
69	Hester Biosciences Ltd.	Q V PT	1,956 Small Cap	2,282.30 (-0.76%)	14.37	4.3	9.19	6.34	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
70	Alkem Laboratories Ltd.	Q V PT	61,277 Mid Cap	5,089.40 (-0.69%)	28.4	4.28	10.66	8.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
71	Blue Jet Healthcare Ltd.	Q V PT	9,547 Small Cap	501.20 (-0.63%)	40.64	4.27	13.68	9.45	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
72	Indegene Ltd.	Q V+ PT	14,164 Small Cap	622.10 (5.86%)	34.45	4.22	29.44	13.80	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
73	Advanced Enzyme Technologies Ltd.	Q V+ PT	2,944 Small Cap	279.60 (6.33%)	29.56	4.15	9.82	13.51	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
74	Aurobindo Pharma Ltd.	Q V+ PT	96,537 Mid Cap	1,666.40 (-0.68%)	37.23	4.12	-6.73	-4.90	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
75	Syncom Formulations (India) Ltd.	Q V+ PT	1,810 Small Cap	19.31 (0.31%)	21.16	4.11	21.49	39.14	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
76	Laxmi Dental Ltd.	Q V PT	978 Small Cap	179 (0.70%)	31.67	3.99	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
77	Piramal Pharma Ltd.	Q V+ PT	31,826 Small Cap	240.60 (0.65%)	N/A	3.91	7.03	-174.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
78	Eris Lifesciences Ltd.	Q V+ PT	16,088 Small Cap	1,175 (1.33%)	22.74	3.88	20.89	11.86	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
79	GPT Healthcare Ltd.	Q V PT	1,089 Small Cap	133.30 (0.45%)	23.04	3.86	14.25	6.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
80	Lupin Ltd.	Q V PT	91,870 Mid Cap	2,025.35 (0.81%)	16.62	3.86	13.02	32.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
81	Amrutanjan Health Care Ltd.	Q V+ PT	1,436 Small Cap	497.10 (0.05%)	26.61	3.83	8.59	1.17	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
82	Pfizer Ltd.	Q V PT	16,867 Small Cap	3,630 (-1.55%)	22.94	3.83	2.39	8.89	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
83	Aarti Pharmalabs Ltd.	Q V+ PT	7,922 Small Cap	897.20 (2.70%)	32.61	3.77	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
84	Fischer Medical Ventures Ltd.	Q V PT	1,729 Small Cap	25.31 (2.26%)	57.98	3.71	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
85	Windlas Biotech Ltd.	Q V PT	1,810 Small Cap	867.15 (-1.15%)	27.24	3.52	16.15	12.78	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
86	Syngene International Ltd.	Q V+ PT	16,252 Small Cap	407.45 (1.20%)	76.91	3.44	9.45	1.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
87	Viyash Scientific Ltd.	Q V PT	9,653 Small Cap	219.90 (0.64%)	56.39	3.43	20.23	2.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
88	Akums Drugs & Pharmaceuticals Ltd.	Q V PT	11,520 Small Cap	732.35 (0.06%)	39.49	3.37	9.87	8.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
89	3B Blackbio Dx Ltd.	Q V PT	1,113 Small Cap	1,337 (3.14%)	20.04	3.34	-8.95	-14.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
90	Orchid Pharma Ltd.	Q V PT	4,989 Small Cap	849.95 (2.03%)	575.67	3.18	22.33	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Narayana Hrudayalay.	1,840.30	7.01%
Advanced Enzyme Tech	279.60	6.33%
Indegene	622.10	5.86%
Themis Medicare	99.84	5.09%
Max Healthcare Inst.	900	4.65%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Sigachi Industries	25.02	-5.23%
Morepen Laboratories	108.05	-4.97%
Concord Biotech	1,189.65	-4.47%
Bliss GVS Pharma	624.10	-3.75%
Artemis MedicareServ	281.55	-3.64%

News about Top Pharma Companies in India

Nov, 2026

Advanced Enzyme Tech - Quaterly Results

The revenue zoomed 18.51% to Rs. 1371.68 millions for the quarter ended September 2026 as compared to Rs. 1157.48 millions during the corresponding quarter last year.Handsome Net Profit growth of 87.17% reported above the corresponding previous quarter figure of Rs. 417.05 millions to Rs. 222.82 millions.Operating profit for the quarter ended September 2026 rose to 543.16 millions as compared to 326.70 millions of corresponding quarter ended September 2025.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	1371.68	1157.48	18.51	2530.25	2407.72	5.09	4527.66	3514.11	28.84
Other Income	163.97	30.79	432.54	186.84	569.31	-67.18	633.88	614.90	3.09
PBIDT	543.16	326.70	66.26	870.15	1170.48	-25.66	1738.22	1321.69	31.51
Interest	0.31	0.49	-36.73	0.68	1.02	-33.33	2.07	2.36	-12.29
PBDT	542.85	326.21	66.41	869.47	1169.46	-25.65	1697.57	1319.33	28.67
Depreciation	31.73	30.02	5.70	60.94	59.31	2.75	120.83	114.05	5.94
PBT	511.12	296.19	72.56	808.53	1110.15	-27.17	1576.74	1205.28	30.82
TAX	94.07	73.37	28.21	168.02	147.52	13.90	258.68	181.08	42.85
Deferred Tax	1.25	0.54	131.48	8.56	0.28	2957.14	-12.01	12.22	-198.28
PAT	417.05	222.82	87.17	640.51	962.63	-33.46	1318.06	1024.20	28.69
Equity	220.53	223.76	-1.44	223.95	223.76	0.08	223.85	223.76	0.04
PBIDTM(%)	39.60	28.23	40.29	34.39	48.61	-29.26	38.39	37.61	2.07

Oct, 2026

Advanced Enzyme Technologies informs about outcome of board meeting

Advanced Enzyme Technologies has informed that the Board of Directors at its meeting held on October 31, 2026 has approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Piramal Pharma informs about SAST

Piramal Pharma has informed that disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HDFC Mutual Fund.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Indegene informs about newspaper advertisement

Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indegene has informed that it enclosed copies of the newspaper advertisement published in Financial Express (English) and Vishwavani (Kannada) today, relating to financial results for 2nd quarter and half year ended September 30, 2026. The above information will be made available on the website of the Company: https://www.indegene.com/.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Vimta Labs - Quaterly Results

A fair growth of 9.95% in the revenue at Rs. 1119.83 millions was reported in the September 2026 quarter as compared to Rs. 1018.48 millions during year-ago period.A meek growth of 3.48% was reported for the quarter ended September 2026 to Rs. 206.14 millions from Rs. 199.20 millions.Operating profit surged to 407.78 millions from the corresponding previous quarter of 368.88 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	1119.83	1018.48	9.95	2210.57	1994.12	10.85	4072.90	3439.82	18.40
Other Income	29.04	26.58	9.26	67.16	44.07	52.39	89.89	42.40	112.00
PBIDT	407.78	368.88	10.55	819.01	723.27	13.24	1505.08	1261.89	19.27
Interest	3.85	3.74	2.94	6.22	6.89	-9.72	11.67	19.00	-38.58
PBDT	403.93	365.14	10.62	812.79	716.38	13.46	1477.25	1242.89	18.86
Depreciation	128.68	102.40	25.66	254.16	201.02	26.44	437.72	352.89	24.04
PBT	275.25	262.74	4.76	558.63	515.36	8.40	1039.53	890.00	16.80
TAX	69.11	63.54	8.77	142.07	127.22	11.67	264.41	222.45	18.86
Deferred Tax	1.58	-3.17	-149.84	16.02	-7.23	-321.58	-1.07	12.66	-108.45
PAT	206.14	199.20	3.48	416.56	388.14	7.32	775.12	667.55	16.11
Equity	89.40	89.08	0.36	89.40	89.08	0.36	89.34	44.47	100.90
PBIDTM(%)	36.41	36.22	0.54	37.05	36.27	2.15	36.95	36.68	0.73

Oct, 2026

Vimta Labs informs about unaudited financial results

Vimta Labs has enclosed unaudited Financial Results as per Regulation 33 of the SEBI (LODR) Regulations, 2015 for the 02nd Quarter and Half Year ended 30th September 2026 along with Limited Review Report. The said Financial Results were duly reviewed and recommended by the Audit Committee and approved by the Board of Directors of the Company, at their respective meetings held today. Further to earlier intimation dated 6th May 2026 regarding the proposed incorporation of a wholly owned subsidiary in the USA, the Board of Directors of the Company, at its meeting held today, took note of the incorporation of Vimta Labs LLC as a wholly owned subsidiary of the Company. The meeting of the Board of Directors of the Company commenced at 10:30 AM and concluded at 01:00 PM.

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Laurus Labs Ltd.	1,29,243 Crore
2	Rubicon Research Ltd.	26,650 Crore
3	Acutaas Chemicals Ltd.	32,770 Crore
4	Glaxosmithkline Pharmaceuticals Ltd.	42,073 Crore
5	CORONA Remedies Ltd.	13,125 Crore
6	Anthem Biosciences Ltd.	46,685 Crore
7	Vijaya Diagnostic Centre Ltd.	14,906 Crore
8	Divis Laboratories Ltd.	2,57,903 Crore
9	Aster DM Quality Care Ltd.	59,570 Crore
10	Thyrocare Technologies Ltd.	7,274 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,738	54,384	33.68	10.51	23.07	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,598	1,76,306	83.01	9.60	33.08	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,383	65,137	36.23	5.94	12.08	27.89
Lupin Ltd. (M)	Somewhat Good	2,025	91,870	16.62	3.86	9.20	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,426	43,891	34.76	9.03	23.33	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,373	1,29,243	147
Sai Life Sciences Ltd. (S)	Somewhat Good	1,565	33,139	69.37
Gland Pharma Ltd. (M)	Very Good	3,069	51,112	61.94
Aurobindo Pharma Ltd. (M)	Very Good	1,666	96,537	52.18
Ipca Laboratories Ltd. (M)	Very Good	1,966	48,907	49.58
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,565	33,139	91.61	12.98	47.25	23.61
Mankind Pharma Ltd. (M)	Very Good	2,511	1,02,797	45.84	5.85	24.28	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,426	43,891	34.76	9.03	23.33	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,238	1,24,089	27.50	4.60	15.32	13.52
Gland Pharma Ltd. (M)	Very Good	3,069	51,112	45.28	4.81	23.17	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,565	33,139	91.61	12.98	47.25	39.96
Lupin Ltd. (M)	Somewhat Good	2,025	91,870	16.62	3.86	9.20	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,383	65,137	36.23	5.94	12.08	22.19
Abbott India Ltd. (M)	Very Good	25,738	54,384	33.68	10.51	23.07	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,357	1,12,699	40.25	2.90	18.79	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Current Complaints

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Advanced Enzyme Tech - Quaterly Results

Advanced Enzyme Technologies informs about outcome of board meeting

Piramal Pharma informs about SAST

Indegene informs about newspaper advertisement

Vimta Labs - Quaterly Results

Vimta Labs informs about unaudited financial results

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?